Contact
Please use this form to send email to PR contact of this press release:
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial
TO:
Please use this form to send email to PR contact of this press release:
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial
TO: